Connect Biopharma Holdings (CNTB) Research & Development (2024 - 2026)
Connect Biopharma Holdings (CNTB) reported Research & Development of $16.27 million for Q2 2026, up 85.5% from $8.77 million a year earlier and up 8.3% from the prior quarter.
Powered by 
Analysis
Connect Biopharma Holdings (CNTB) Research & Development (2024 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Connect Biopharma Holdings' Research & Development came in at $53.7 million, up 75.2% year-over-year; for FY2025, it came in at $37.8 million, up 29.2% from FY2024.
- By year, Research & Development came in at $29.26 million in FY2024 (-44.8%) and $53 million in FY2023.
- The Q2 2026 figure ranks as the highest quarterly Research & Development in data going back to Q1 2024.
- Year over year, Research & Development has now increased in each of the last five quarters, with growth averaging 59.5% over the last six quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $15.03 million (Q1 2026), $11.28 million (Q4 2025) and $11.11 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.62 Bn | 1,103.20 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 616.94 Bn | 535.47 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 501.32 Bn | 474.43 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 367.44 Bn | 321.82 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.20 Bn | 262.19 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.78 Bn | 235.47 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 235.70 Bn | 191.10 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 190.88 Bn | 165.07 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 169.72 Bn | 116.36 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Connect Biopharma Holdings | 51.82 Mn | -124.85 Mn | - | 16.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.27 Mn |
| Mar 31, 2026 | 15.03 Mn |
| Dec 31, 2025 | 11.28 Mn |
| Sep 30, 2025 | 11.11 Mn |
| Jun 30, 2025 | 8.77 Mn |
| Mar 31, 2025 | 6.63 Mn |
| Dec 31, 2024 | 6.24 Mn |
| Sep 30, 2024 | 9.01 Mn |
| Jun 30, 2024 | 5.35 Mn |
| Mar 31, 2024 | 8.66 Mn |
API Access
Connect Biopharma Holdings Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CNTB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CNTB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CNTB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();